Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
MOUNJARO is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Contraindications (4)]
The World Health Organization has issued multiple warnings about fake semaglutide found in international markets, and the FDA has seized hundreds of counterfeit Ozempic units
The STEP trial series demonstrated that semaglutide 2.4 mg weekly produces approximately 17-22% weight reduction from baseline over 68 weeks
Consensus-Based Guidance on Preoperative Management of Patients on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists American Society of Anesthesiologists Pharmacodynamics, pharmacokinetics, safety and tolerability of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 after single subcutaneous administration in healthy subjects - Diabetes, Obesity and Metabolism Mounjaro (tirzepatide) injection, for subcutaneous use (2022) Zepbound (tirzepatide) injection, for subcutaneous use (2023)
History of pancreatitis or gallbladder disease, because these conditions may worsen with GLP-1 medications
Discover expert-backed wellness resources
US$ 20.20
US$ 20.66
US$ 20.20
US$ 23.21
US$ 28.09
US$ 26.26
